Physician profile
Jason J Durel
NPI 1669664934
$4,351.26
in general payments reported to CMS, 2019-2025
24 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $319 · 2021: $1,156 · 2022: $229 · 2023: $311 · 2024: $965 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Travel and Lodging: $442 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,512.59 |
| Travel and Lodging | $442.03 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $886.95 | 2019-2025 | |
| Optinose US, INC. | $556.21 | 2019-2025 | |
| Genzyme Corporation | $442.73 | 2021-2025 | |
| Smith+Nephew, INC. | $442.03 | 2024 | Coblation |
| Stryker Corporation | $345.00 | 2019-2025 | Scopis Ent, Audion Et Dilation System |
| Regeneron Healthcare Solutions, INC. | $323.90 | 2020-2025 | Dupixent |
| Intersect Ent, INC. | $319.20 | 2019-2020 | |
| Glaxosmithkline, LLC. | $222.03 | 2019-2025 | Nucala |
| Inspire Medical Systems, INC. | $122.13 | 2025 | Inspire |
| Allergan, INC. | $83.07 | 2019-2020 | |
| Phadia US INC. | $79.82 | 2020-2021 | |
| Kaleo, INC. | $79.15 | 2019-2024 | Auvi-Q |
| Acclarent, INC | $67.94 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $57.33 | 2025 | Neffy |
| Amgen INC. | $55.44 | 2025 | Tezspire |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $47.99 | 2019 | |
| Alk-Abello, INC | $46.97 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $35.27 | 2019-2025 | Tezspire |
| Hikma Pharmaceuticals USA | $34.59 | 2023-2024 | Ryaltris |
| Spirair, INC. | $27.98 | 2024 | Septalign |
| Ambu INC. | $26.54 | 2020 | |
| Paratek Pharmaceuticals, INC. | $19.51 | 2025 | Xhance |
| Ethicon US, LLC | $17.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Durel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.